Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REOLYSIN plus paclitaxel/carboplatin versus chemotherapy alone in recurrent or metastatic squamous cell carcinoma of the head and neck
2009-016940-38Phase 3Completed
- Sponsor
- Oncolytics Biotech Inc.
- Start
- Feb 2010
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal squamous cell carcinoma comparing REOLYSIN + paclitaxel + carboplatin with Placebo + paclitaxel + carboplatin (2 arms). Primary endpoint: Overall Survival. Started Feb 2010; status: completed.
02
Drugs
pelareorep
03
Conditions
head and neck squamous cell carcinoma (HNSCC)nasopharyngeal squamous cell carcinoma
Beyond the preview
Go deeper on 2009-016940-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016940-38.